Press Releases + New

Date	Title and Summary	View
Toggle SummarySep 13, 2010	PRO-PHARMACEUTICALS COLLABORATES WITH NUMODA TO MANAGE PHASE lll CLINICAL TRIAL TO INCREASE SPEED-TO-MARKET FOR DAVANAT®	View HTML PRO-PHARMACEUTICALS COLLABORATES WITH NUMODA TO MANAGE PHASE lll CLINICAL TRIAL TO INCREASE SPEED-TO-MARKET FOR DAVANAT® 16.9 KB
Toggle SummarySep 10, 2010	PRO-PHARMACEUTICALS' PRESENTATION AT RODMAN AND RENSHAW'S ANNUAL GLOBAL INVESTMENT CONFERENCE TO BE WEBCAST LIVE	View HTML PRO-PHARMACEUTICALS' PRESENTATION AT RODMAN AND RENSHAW'S ANNUAL GLOBAL INVESTMENT CONFERENCE TO BE WEBCAST LIVE 16.5 KB
Toggle SummaryAug 24, 2010	PRO-PHARMACEUTICALS' EXECUTIVES TO PRESENT CORPORATE UPDATE AT THREE INVESTOR CONFERENCES IN SEPTEMBER Rodman and Renshaw Annual Global Investment Conference; BioPharm America 2010 MassBio Investors Forum, and Accredited Members Fall 2010 Small/Micro Cap Conference	View HTML PRO-PHARMACEUTICALS' EXECUTIVES TO PRESENT CORPORATE UPDATE AT THREE INVESTOR CONFERENCES IN SEPTEMBER 15.3 KB
Toggle SummaryAug 13, 2010	PRO-PHARMACEUTICALS REPORTS SECOND QUARTER 2010 AND SIX MONTHS FINANCIAL RESULTS	View HTML PRO-PHARMACEUTICALS REPORTS SECOND QUARTER 2010 AND SIX MONTHS FINANCIAL RESULTS 18.1 KB
Toggle SummaryJun 22, 2010	PRO-PHARMACEUTICALS RECEIVES FIRST COMMERCIAL ORDER FOR DAVANAT® PROCAPS S.A. To Make Upfront Payment and Will Be Responsible for the Approval, Distribution, Marketing and Sales of DAVANAT® in Colombia	View HTML PRO-PHARMACEUTICALS RECEIVES FIRST COMMERCIAL ORDER FOR DAVANAT® 19.3 KB
Toggle SummaryJun 15, 2010	FORMER GLAXO SMITH KLINE CHIEF MEDICAL OFFICER PETER G. TRABER, M.D., NAMED CHIEF MEDICAL OFFICER OF PRO-PHARMACEUTICALS Dr. Traber Will Lead Design of Phase lll Colorectal Cancer Trial for DAVANAT® and the Company's FDA Approval Strategy	View HTML FORMER GLAXO SMITH KLINE CHIEF MEDICAL OFFICER PETER G. TRABER, M.D., NAMED CHIEF MEDICAL OFFICER OF PRO-PHARMACEUTICALS 18.3 KB
Toggle SummaryMay 24, 2010	PRO-PHARMACEUTICALS PREPARES PHASE III DAVANAT® TRIAL FOR SECOND HALF 2010 Peter G. Traber, M.D. Joins Trial Design Team to Finalize and Implement Strategy for FDA Approval	View HTML PRO-PHARMACEUTICALS PREPARES PHASE III DAVANAT® TRIAL FOR SECOND HALF 2010 16.4 KB
Toggle SummaryMay 12, 2010	PRO-PHARMACEUTICALS REPORTS FIRST QUARTER 2010 FINANCIAL RESULTS	View HTML PRO-PHARMACEUTICALS REPORTS FIRST QUARTER 2010 FINANCIAL RESULTS 16.2 KB
Toggle SummaryMay 11, 2010	PRO-PHARMACEUTICALS CLOSES FINAL $570,000 TRANCHE FROM 10X FUND TO COMPLETE $6 MILLION RAISE	View HTML PRO-PHARMACEUTICALS CLOSES FINAL $570,000 TRANCHE FROM 10X FUND TO COMPLETE $6 MILLION RAISE 17.1 KB
Toggle SummaryMay 04, 2010	PRO-PHARMACEUTICALS CLOSES $310,000 TRANCHE FROM 10X FUND	View HTML PRO-PHARMACEUTICALS CLOSES $310,000 TRANCHE FROM 10X FUND 16.2 KB